Shares of Progyny, Inc. (NASDAQ: PGNY - Get Free Report) have been given an average rating of "Moder

AWM Investment Company Inc. bought a new position in shares of Progyny, Inc. (NASDAQ: PGNY) during t

MNDY, MTCH, PGNY and WK make the cut as the top liquid stocks, each boasting strong liquidity, growt

JP Morgan analyst Lisa Gill maintains Progyny (NASDAQ:PGNY) with a Neutral and raises the price t

Wells Fargo analyst Stan Berenshteyn initiates coverage on Progyny (NASDAQ:PGNY) with a Overweigh

Bank of America Corp DE boosted its stake in shares of Progyny, Inc. (NASDAQ: PGNY) by 75.3% during

Progyny NASDAQ: PGNY CEO Pete Anevski said the company expects member engagement and utilization to

Truist Securities analyst Jailendra Singh maintains Progyny (NASDAQ:PGNY) with a Buy and raises t

California State Teachers Retirement System lifted its position in shares of Progyny, Inc. (NASDAQ:

Barclays analyst Peter Warendorf maintains Progyny (NASDAQ:PGNY) with a Equal-Weight and lowers t

On August 11, 2026, Progyny Inc (PGNY) shares fell by 4.6%, bringing the current price to $26.55. Th

IVZ, HUBS, HNGE and PGNY make the cut as the top liquid stocks, each boasting strong liquidity, grow

Progyny stock initially plummeted this morning but has steadily marched back toward even.

NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's

Gainers Doximity (NYSE:DOCS) stock rose 85.1% to $38.25 during Friday's pre-market session. The

Progyny NASDAQ: PGNY reported record quarterly revenue, gross profit and adjusted EBITDA for the sec

Progyny, Inc. (PGNY) Q2 2026 Earnings Call Transcript

Although the revenue and EPS for Progyny (PGNY) give a sense of how its business performed in the qu

Progyny (PGNY) came out with quarterly earnings of $0.55 per share, beating the Zacks Consensus Esti

Gainers Doximity (NYSE:DOCS) stock increased by 65.6% to $34.22 during Thursday's after-market

Progyny (NASDAQ:PGNY) is looking for Q3 Adj EPS of $0.50-$0.52 vs $0.33 analyst estimate. sees sales

Progyny (NASDAQ:PGNY) raises FY2026 Adj EPS guidance from $1.98-$2.09 to $2.04-$2.10 vs $1.29 analys

Progyny (NASDAQ:PGNY) reported quarterly earnings of $0.55 per share which beat the analyst consensu

Progyny (PGNY) doesn't possess the right combination of the two key ingredients for a likely earning

Wall Street analysts change outlook on top stocks. See upgrade, downgrade, and initiation changes on

Barclays analyst Peter Warendorf downgrades Progyny (NASDAQ:PGNY) from Overweight to Equal-Weight

BTIG analyst David Larsen maintains Progyny (NASDAQ:PGNY) with a Buy and raises the price target

NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's

Canaccord Genuity analyst Richard Close maintains Progyny (NASDAQ:PGNY) with a Buy and raises the

Melissa B. Cummings disposed of 3,437 shares for a total value of ~$109,000 on July 14, 2026. The tr

JBHT, PGNY, BSET, VSXY and PARR stand out for relative price strength, positive estimate revisions a

Warning: RSI is above 70 for 3 overbought stocks in healthcare. Progyny, 10X Genomics, and Privia He

Progyny (PGNY) is at a 52-week high, but can investors hope for more gains in the future? We take a

Keybanc analyst Scott Schoenhaus maintains Progyny (NASDAQ:PGNY) with a Overweight and raises the

Progyny (PGNY) shares have started gaining and might continue moving higher in the near term, as ind

Truist Securities analyst Jailendra Singh maintains Progyny (NASDAQ:PGNY) with a Buy and raises t

B of A Securities analyst Michael Cherny maintains Progyny (NASDAQ:PGNY) with a Buy and raises th

Top Wall Street analysts upgraded STUB, PGNY, AMT, and BAP stocks and raised their price targets. Se

Canaccord Genuity analyst Richard Close upgrades Progyny (NASDAQ:PGNY) from Hold to Buy and raise

Barclays analyst Glen Santangelo maintains Progyny (NASDAQ:PGNY) with a Overweight and raises the

Truist Securities analyst Jailendra Singh maintains Progyny (NASDAQ:PGNY) with a Buy and raises t

Citizens analyst Constantine Davides maintains Progyny (NASDAQ:PGNY) with a Market Outperform and

Progyny (NASDAQ:PGNY) is looking for Q2 Adj EPS of $0.50-$0.53 vs $0.33 analyst estimate. sees sales

Progyny (NASDAQ:PGNY) raises FY2026 Adj EPS guidance from $1.83-$1.95 to $1.98-$2.09 vs $1.32 analys

Progyny (NASDAQ:PGNY) reported quarterly earnings of $0.50 per share which beat the analyst consensu

Available in the U.S., Progyny Select enables small employers to have access to fertility solutions

Barclays analyst Glen Santangelo maintains Progyny (NASDAQ:PGNY) with a Overweight and lowers the

On March 13, 2026, Progyny, Inc. (the "Company") issued a Notice of Pendency of Settlement o